arrow
L

Lorenzo Gervaso

irccs european institute of oncology (ieo)
H指数:11
被引数:746

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Development and validation of an epidemiological risk score for early detection of pancreatic cancer in high-risk individuals within the IMAGene project

在IMAGene项目中开发并验证用于高危人群早期检测胰腺癌的流行病学风险评分

2026-05-200
PRE
Rate and risk factors of venous thromboembolism during neoadjuvant chemotherapy for advanced ovarian cancer: a retrospective analysis from a referral center

晚期卵巢癌新辅助化疗期间静脉血栓栓塞的发生率及危险因素:一家转诊中心的回顾性分析

2026-04-030
PRE
Anti-EGFR rechallenge compared with standard of care for patients with ctDNA RAS/BRAF wild-type chemorefractory metastatic colorectal cancer: a systematic review and meta-analysis
2026-02-040
PRE
Total neoadjuvant therapy followed by non-operative management or surgery in stage II–III rectal cancer (NO-CUT): a multicentre, single-arm, phase 2 trial

总新辅助治疗继之以非手术治疗或手术治疗的II~III期直肠癌(NO-CUT):一项多中心、单臂、II期临床试验

2025-11-240
PRE
A Comparative Study of Methyl-BEAMing and Droplet Digital PCR for MGMT Gene Promoter Hypermethylation Detection

甲基BEAMing和液滴数字PCR检测MGMT基因启动子甲基化的比较研究

2024-11-050
OA
Carcinoid heart disease in patients with advanced small-intestinal neuroendocrine tumors and carcinoid syndrome: a retrospective experience from two European referral centers

晚期小肠神经内分泌肿瘤和类癌综合征患者的类癌心脏病: 来自两个欧洲转诊中心的回顾性经验

2024-11-010
OAAI
An Italian multicenter phase II trial of metronomic temozolomide in unfit patients with advanced neuroendocrine neoplasms: Interim analysis of the MeTe study

一项关于米兰多中心II期试验中,在不符合条件的晚期神经内分泌肿瘤患者中应用节律性替莫唑胺的意大利研究:MeTe研究的期中分析

2024-09-010
PRE
Circulating tumor DNA in patients with locally advanced rectal cancer treated with multimodal treatment
2024-06-130
OAAI